COMMON HARMS · HEART WARNING · SKIN COLOR
PT-141 Side Effects found in controlled studies
Nausea occurred most often. Warmth, red skin, and headache followed. This page also covers blood-pressure trouble and personal reports.
What the drug may do to your body
Bremelanotide, known in research as PT-141, most often causes nausea. In a long study, about two in five women felt sick [4].
Nausea was the top reason women quit. Headache and skin that felt warm and looked red were also common [4].
A brief increase can affect your blood pressure. The label forbids the drug if your high pressure is uncontrolled or heart disease is known [6].
Frequent doses may make your skin, gums, or breasts darker [6]. The page ends with personal reports that trials haven't tested together.
What heart and blood-pressure trouble rules out use
A bremelanotide dose may briefly increase blood pressure and lower heart rate a little. The label forbids use if treatment has not controlled your high pressure [6].
The same rule applies when heart or blood-vessel disease is known. Small studies that followed pressure across the day found the rise [6].
Treat this as more than a passing nuisance. If you're weighing PT-141, discuss your heart and pressure history early with your doctor [6].
How often nausea, warm red skin, and headache occurred
A 52-week follow-up included 684 women. Drug-related nausea affected 40.4%, skin became warm and red in 20.6%, and headache affected 12.0% [4].
The longer study did not uncover another type of harm, and desire gains continued. Even so, nausea led many women to stop [4].
The main Phase 3 studies, the large final trials, found the same three common problems [3]. Some women also had a sore needle spot or stuffy nose [3][9].
Nausea often began early. Researchers studied ways to manage it because it caused so many women to quit [4].
Against placebo, average desire improved by 0.35 points and distress by 0.33 points [3][10]. Question 13 asked how much low desire troubled each woman.
That leaves a clear choice to discuss with a doctor. You would weigh a small average benefit against a common chance of nausea.
What may darken skin, gums, or breasts
Frequent repeat doses may darken skin, gums, or breasts. The drug can increase melanin, the substance that gives skin its color [6].
One cell switch affected by PT-141 is tied to desire. Another helps set skin color, which explains this unwanted change [8].
The warning appears in the drug label, not just in personal reports. The risk is tied most closely to frequent repeat use [6].
Doctors may call this hyperpigmentation, which simply means part of the body gets darker. The dark area may not fully fade.
Why a journal warned readers about one older study
In 2023, a journal warned readers about a study published in 2008 by Safarinejad and Hosseini. The paper covered erection trouble, and we don't rely on its disputed findings [10].
Such a warning shows that the journal has serious doubts about the work. It doesn't prove every claim in the paper is false.
This matters because evidence in men is already thin. Read more about the early erection studies that weren't approved.
We name the dispute so the weak spot stays visible to you. The warning remains part of the record [10].
What research users report outside controlled studies
These are personal accounts from research users. Controlled studies didn't gather or test them together, so the accounts aren't proof or advice.
People online often describe warm, red skin in the first hour and nausea soon after. Some say nausea eases with repeat use, though trials haven't proved that claim.
Men also describe desire that seems to begin in the mind instead of only in the body. These stories cannot establish a benefit in men.
Posts also link frequent use with darker facial skin. That report matches the label warning about changes in skin color [6].
Controlled studies carry more weight: nausea was about 40%, skin warmth and redness near 21%, and headache near 12%. The blood-pressure warning also comes from the label, not these posts [4][6].